Arch Therapeutics Inc (ARTH)

[Snowy_Owl]

I agree or at least I think I do. I think ARTH needs to get to a point where they are encroaching on J&J and/or Bayer’s market share enough to initiate a buyout. A bidding war would be nice but I think one will strike early and buy cheap.

Norchi has the academic credentials but may be lacking in jungle warfare. I think the future hangs heavily on the recently hired talent and experience.

I don’t want more dilution.

“so ARTH must become an operational success for it to become a winner for investors.”